글로벌 측면 흐름 분석 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

측면 흐름 분석(LFA)은 반세기 전에 의료, 환경 테스트, 식품 및 음료를 포함한 다양한 응용 분야에서 진단을 돕기 위해 개발되었습니다. 진료소 진단 설정에서 LFA를 사용하는 것은 연구 커뮤니티에서 상당한 인기를 얻었으며, 측면 흐름 분석 시장의 성장을 촉진했습니다.

Data Bridge Market Research는 측면 흐름 분석 시장이 2029년까지 127억 5천만 달러 규모에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 8.29%에 이를 것으로 분석했습니다. 가정용 측면 흐름 테스트 제품 및 솔루션에 대한 높은 소비율과 더 나은 진료 시점 테스트 제품에 대한 필요성이 결합되어 2022년부터 2029년까지 측면 흐름 분석 시장이 성장할 것입니다.

시장 정의

측면 흐름 검사는 항체와 프로브 DNA의 생화학적 상호작용을 포함하는 진단 기술입니다. 이 방법은 검사가 매우 단순화된 방식으로, 낮은 비용으로, 어떠한 간섭도 없이 수행되도록 보장합니다. 또한 매우 사용자 친화적인 검사 형태를 기반으로 하기 때문에 훈련받지 않은 사람도 수행할 수 있습니다.

보고 범위 및 시장 세분화

Lateral flow assay Market Dynamics

Drivers

• The rapid antigen testing promotes market growth

Rapid antigen testing at the point of care is possible with lateral flow assay devices, which can provide results in less time than ELISA tests. Furthermore, lateral flow assay tests have been rapidly adopted in the veterinary sector, boosting overall market growth.

• The significant collaborations among key market players

Technological advancements and significant collaboration efforts among key pharmaceutical industry players, funding programmes, and the presence of reimbursement agencies will drive even higher demand for lateral flow rapid test diagnostics.

• Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the lateral flow assay market.

Opportunities

New techniques, such as CAD and CAM technologies, have reduced design time and increased precision in procedures such as implant placement. Computer-generated virtual treatment aids dental doctors in providing patients with a better fit and deciding where to place implants in patients. Such factors are expected to drive the market's overall expansion.

Restraints/Challenges

The high cost of lateral flow assay is a significant barrier to market growth. A lack of awareness and a scarcity of professional dentists are impeding market growth in low-income countries.

This lateral flow assay market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lateral flow assay market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Lateral Flow Assay Market

Since the outbreak of the novel coronavirus (COVID-19), there has been an urgent need for diagnostic solutions, including lateral flow assays, as they are a critical component of the COVID-19 pandemic management. COVID-19 incidence increased exponentially across countries by 2020, prompting key operating players to invest in R&D for rapid tests. As a result, several antibody/antigen tests have been launched.

.Recent Development

• Eurofins Technologies will launch its RapidScan ST5-W lateral flow reader in December 2021, designed for field and in-process testing applications requiring qualitative to semi-quantitative test results.
• Abbott announced in January 2021 that it had received CE Mark for two new applications of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus.

Global Lateral Flow Assay Market Scope

The lateral flow assay market is segmented on the basis of product, technique, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product                                                                            

• Kits and Reagents
• Lateral flow readers

Based on product, the lateral flow assay market is segmented into kits & reagents and lateral flow readers. Kits & reagents have been sub-segmented into test strip, dipstick, cassette and lancets; Lateral flow readers are sub-segmented into digital/mobile readers and benchtop readers.

Technique

• Sandwich assays
• Competitive assays
• Multiplex detection assays

Based on technique, the lateral flow assay market is segmented into sandwich assays, competitive assays and multiplex detection assays.

End User

• Hospitals and Clinics
• Home care
• Pharma and biotech companies
• Diagnostic laboratories
• Others

On the basis of end user, the lateral flow assay market is segmented as hospitals & clinics, home care, pharmaceutical & biotechnology companies, diagnostic laboratories and others.

Application

• clinical/POCT testing
• veterinary diagnostics
• food safety & environment testing
• drug development & quality testing

On the basis of application, the lateral flow assay market is segmented into clinical/POCT testing, veterinary diagnostics, food safety & environment testing and drug development & quality testing. Clinical/POC (Point-of-Care) testing is sub-segmented into infectious disease testing, cardiac marker testing, pregnancy & fertility testing, cholesterol testing/lipid profile, drugs of abuse testing and other clinical/POC (Point-of-Care) testing. Infectious disease testing is sub-segmented into mosquito-borne disease testing, influenza testing, sexually transmitted infection testing, hepatitis, tuberculosis and other infectious disease tests. Sexually transmitted infection testing are further segmented into HIV testing, HPV testing, chlamydia testing, gonorrhoea testing, syphilis testing and other sexually transmitted infection testing. Cardiac marker testing are sub-segmented into troponin I & T testing, CK-MB testing, BNP & NT-Propbnp Testing, myoglobin testing, D-dimer testing and other cardiac marker tests. Pregnancy & fertility testing are sub-segmented into pregnancy testing and fertility testing.

• Distribution channel
• Hospital pharmacies
• Retail pharmacies
• Supermarket/hypermarket
• e-commerce

Lateral flow assay market has also been segmented into hospital pharmacies, retail pharmacies, supermarket/hypermarket and e-commerce on the basis of distribution channel.

Lateral Flow Assay Market Regional Analysis/Insights

The lateral flow assay market is analysed and market size insights and trends are provided by country, product, technique, application, end user and distribution channel as referenced above.

The countries covered in the lateral flow assay market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The lateral flow assay market will be dominated by North America. The availability of advanced healthcare infrastructure and services, as well as rising incidences of target chronic disorders due to the region's growing geriatric population, are expected to strengthen this region's position. Collaboration on innovations and advancements with other market players has been one of the major factors driving this market's significant growth potential due to the presence of major market players in the region.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

측면 흐름 분석 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 측면 흐름 분석 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 측면 흐름 분석 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 측면 흐름 분석 시장 점유율 분석

측면 흐름 분석 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 측면 흐름 분석 시장과 관련된 회사의 초점에만 관련이 있습니다.

측면 흐름 분석 시장에서 운영되는 주요 업체 중 일부는 Beckman Coulter, Inc.(미국)입니다.

• STRATEC SE(독일)
• 퍼킨엘머 주식회사(미국)
• DRG International, Inc. (미국)
• MP 바이오메디컬스(미국)
• 시스비오(프랑스)
• Euro Diagnostica AB(스웨덴)
• Tecan Trading AG(스위스)
• DiaSorinS.pA(이탈리아)
• EMD 밀리포어(미국)
• iZotope, Inc. (미국)
• DIAsource(미국)
• Berthold Technologies GmbH & Co. KG(독일)

SKU-26074